Clinical Trial Detail

NCT ID NCT02576444
Title OLAParib COmbinations
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Yale University
Indications

Advanced Solid Tumor

Therapies

MK-1775 + Olaparib

Olaparib

Olaparib + Vistusertib

AZD5363 + Olaparib

Age Groups: adult

Additional content available in CKB BOOST